Alexandria Hammond
Stock Analyst at B of A Securities
(0.7)
# 2227
Out of 5,329 analysts
14
Total ratings
60.00%
Success rate
-1.75%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
AKRO Akero Therapeutics | Upgrades: Buy | 35 63 | 45.42 | 38.71% | 2 | Jan 30, 2025 | |
REGN Regeneron Pharmaceut... | Initiates Coverage On: Outperform | 1150 | 588.6 | 95.38% | 1 | Nov 15, 2024 | |
PFE Pfizer | Initiates Coverage On: Underperform | 25 | 23.91 | 4.56% | 1 | Nov 15, 2024 | |
MRNA Moderna | Initiates Coverage On: Underperform | 40 | 27.05 | 47.87% | 1 | Nov 15, 2024 | |
MRK Merck & Co | Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 1000 | 794.79 | 25.82% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 190 | 154.43 | 23.03% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 110 | 103.22 | 6.57% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 205 | 193.41 | 5.99% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Underperform | 150 | 326.72 | -54.09% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 30 | 8.13 | 269% | 1 | Apr 22, 2024 |